Omnicell (OMCL) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Powered by 
Analysis
Omnicell (OMCL) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 113.85% |
| Mar 31, 2026 | 660.61% |
| Dec 31, 2025 | -137.09% |
| Sep 30, 2025 | -3.14% |
| Jun 30, 2025 | 180.29% |
| Mar 31, 2025 | -144.33% |
| Dec 31, 2024 | 83.57% |
| Sep 30, 2024 | 131.06% |
| Jun 30, 2024 | 123.89% |
| Mar 31, 2024 | -8.74% |
| Dec 31, 2023 | -358.87% |
| Sep 30, 2023 | 60.91% |
| Jun 30, 2023 | 123.03% |
| Mar 31, 2023 | 47.27% |
| Dec 31, 2022 | -269.39% |
| Sep 30, 2022 | 84.96% |
| Jun 30, 2022 | 10.42% |
| Mar 31, 2022 | -41.26% |
| Dec 31, 2021 | -52.31% |
| Sep 30, 2021 | 43.54% |